Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes
Open accessAbstract
Aims/hypothesis Three hallmarks of the pancreatic islets in early human type 1 diabetes are overexpression of HLA class I, endoplasmic reticulum (ER) stress and beta cell apoptosis. The mediators of these phenomena remain to be defined. The type I interferon IFNα is expressed in human islets from type 1 diabetes patients and mediates HLA class I overexpression. We presently evaluated the mechanisms involved in IFNα-induced HLA class I expression in human beta cells and determined whether this cytokine contributes to ER stress and apoptosis. Methods IFNα-induced inflammation, ER stress and apoptosis were evaluated by RT-PCR, western blot, immunofluorescence and nuclear dyes, and proteins involved in type I interferon signalling were inhibited by small interfering RNAs. All experiments were performed in human islets or human EndoC-βH1 cells. Results IFNα upregulates HLA class I, inflammation and ER stress markers in human beta cells via activation of the candidate gene TYK2, and the transcription factors signal transducer and activator of transcription 2 and IFN regulatory factor 9. Furthermore, it acts synergistically with IL-1β to induce beta cell apoptosis. Conclusions/interpretation The innate immune effects induced by IFNα may induce and amplify the adaptive immune response against human beta cells, indicating that IFNα has a central role in the early phases of diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Over 40% of genes associated with type 1 diabetes are expressed in the islet or beta cell.
“More recently, there has been increased focus on whether many of these variants may influence beta cell interactions with the immune system, with over 40% of genes associated with type 1 diabetes being expressed in the islet or beta cell.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [55]
The Discussion (page unavailable) describes type 1 diabetes candidate genes expressed in human pancreatic islets, supporting the qualitative point. It gives no proportion of all associated genes expressed in islets or beta cells, so it does not support the “over 40%” figure. (LLM, conf=0.77)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Benner, C., van der Meulen, T., Cacéres, E., Tigyi, K., Donaldson, C. J., & Huising, M. O. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-620 · Cited by 302 · see citing works
Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
Richardson, S. J., Rodriguez-Calvo, T., Gerling, I. C., Mathews, C. E., Kaddis, J. S., Russell, M. A., Zeissler, M., Leete, P., Krogvold, L., Dahl-Jørgensen, K., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4067-4 · Cited by 298 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors
Stamatouli, A. M., Quandt, Z., Perdigoto, A. L., Clark, P. L., Kluger, H., Weiss, S. A., Gettinger, S., Sznol, M., Young, A., Rushakoff, R., et al. (2018) · Diabetes · doi:10.2337/dbi18-0002 · Cited by 590 · see citing works
100 years of insulin: celebrating the past, present and future of diabetes therapy
Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A., & Evans-Molina, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01418-2 · Cited by 270 · see citing works
Type I interferons and endoplasmic reticulum stress in health and disease
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.004 · Cited by 83 · see citing works
Approaches and advances in the genetic causes of autoimmune disease and their implications
Inshaw, J. R. J., Cutler, A. J., Burren, O. S., Stefana, M. I., & Todd, J. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0129-8 · Cited by 70 · see citing works
- Authors
- Marroqui, L., Dos Santos, R. S., Op de beeck, A., Coomans de Brachène, A., Marselli, L., Marchetti, P., & Eizirik, D. L.
- Affiliations
- University of Pisa (IT)
- Université Libre de Bruxelles (BE)
- Corresponding author
- Eizirik, Decio L.
- Venue
- Diabetologia
- Published
- 2017-01-06
- Volume
- 60
- Issue
- 4
- Pages
- 656-667
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2570554925
- Cited by
- 203
- References
- 2
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 17 · 2023: 21 · 2022: 25 · 2021: 32 · 2020: 18 · 2019: 14 · 2018: 16 · 2017: 6
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- Funders
- Innovative Medicines Initiative 2 Joint Undertaking (No 115797 (INNODIA))
- Horizon 2020 Program (T2Dsystems - GA667191)
- Fonds National de la Recherche Scientifique, Belgium (T.0036.13)
- NIH-NIDDK-HIRN Consortium (1UC4DK104166-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- interferon-alpha, type 1 diabetes, beta-cell apoptosis, endoplasmic reticulum stress, pancreatic islets, TYK2, STAT2, IRF9, IL-1β, innate immune response, autoimmunity, EndoC-βH1 cells
- MeSH terms
- Cell Line, Cell Survival, Diabetes Mellitus, Type 1, Flow Cytometry, Fluorescent Antibody Technique, Humans, Transcription Factors, Blotting, Western, Histocompatibility Antigens Class I, Signal Transduction, Interferon-alpha, Apoptosis, RNA Interference, Insulin-Secreting Cells, Interleukin-1beta, Endoplasmic Reticulum Stress, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review